4//SEC Filing
Menzaghi Frederique Ph.D. 4
Accession 0001209191-21-070816
CIK 0001346830other
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 5:32 PM ET
Size
5.2 KB
Accession
0001209191-21-070816
Insider Transaction Report
Form 4
Menzaghi Frederique Ph.D.
VP-Research & Development
Transactions
- Award
Common Stock
2021-12-17+12,607→ 153,679 total
Footnotes (1)
- [F1]Represents the number of shares underlying restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest as to (i) 50% on December 15, 2022; and (ii) 50% on June 15, 2023, subject to the Reporting Person's continued service with the Issuer through each such vesting date.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001597152
Filing Metadata
- Form type
- 4
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 5:32 PM ET
- Size
- 5.2 KB